NDC Code(s) : 66914-2327-9, 66914-2328-9
Packager : Baxter Pharmaceutical Solutions, LLC
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
YERVOYipilimumab INJECTION | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
YERVOYipilimumab INJECTION | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
FOR EXPORT
YERVOY (IPILIMUMAB) SOLUTION INJECT 50MG/10ML 1X10ML VIAL VE
1 CASE X 12 VIALS X 10 MILLILITER
REFRIGERATE AT 2°C TO 8°C (36°F TO 46°F).
DO NOT FREEZE OR SHAKE. PROTECT FROM LIGHT.
MANUFACTURED BY: BRISTOL-MYERS SQUIBB COMPANY
PRINCETON, NEW JERSEY 08543 USA
PRINCIPAL DISPLAY PANEL
FOR EXPORT
YERVOY (IPILIMUMAB) SOLUTION INJECT 200MG/40ML 1X40ML VIAL VE
1 CASE X 10 VIALS X 40 MILLILITER
REFRIGERATE AT 2°C TO 8°C (36°F TO 46°F).
DO NOT FREEZE OR SHAKE. PROTECT FROM LIGHT.
MANUFACTURED BY: BRISTOL-MYERS SQUIBB COMPANY
PRINCETON, NEW JERSEY 08543 USA